D Ragavan,Sector Cluster LeadSouth Asia Siemens Healthcare
Over the last few years, medical technology is primarily being focused on early and accurate diagnosis, faster and better treatment planning and effective follow up. Imaging technology is focusing on early detection and diagnosis, thus enabling higher chances of cure and correction. This also helps in using technology for preventive care rather than treatment after disease occurrence.
It is now possible to detect minute lesions in the body with great precision and resolution with imaging technologies such as Ultrasound, CT, MRI, PET/CT, etc. at an early stage. For example, with Siemens PET.CT, a physician can detect a lesion as small as 2 mm anywhere in the field of view. Another example is, Acoustic Radiation Force Impulse (ARFI) technology using ultrasound, which helps in diagnosing liver ailments at a much earlier stage and without biopsies.
In the field of clinical chemistry and blood analysis, technology plays a significant part. A drop of blood sample can now provide insight into an array of diseases and symptoms that might strike a person. We have also made advancements in the area of molecular diagnosis, which can provide a profile of a patient’s genetic variation that can indicate susceptibility to a certain disease before the symptoms occur.
For over 100 years, Siemens has been investing extensively in R&D. On an average, we spend close to 10 percent of our revenues in research and development. Dual Source CT scanners, Tim Technology for the MR, DynaCT on Cathlabs, ARFI based Ultrasound are some of the prominent examples of our Innovation leadership. We will continue this tradition of focus on research and development.